Study summary

Eltrombopag beat steroids or IVIG as first treatment for children with ITP

PINES trial · 118 children, phase 3 · Published November 2025, JAMA

65%sustained platelet response, vs 35%

What was tested

Eltrombopag, a daily pill that boosts platelet production, against standard first-line treatment (steroids, IVIG or anti-D), for children with newly diagnosed ITP needing treatment.

What they found

What it means

May move platelet-boosting pills earlier in children.

JAMA, via PubMed ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.